medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-20-76-79medsovet-2233Research ArticleБРОНХОПУЛЬМОНОЛОГИЯ, ЛОРBRONCHOPULMONOLOGY, ENTАЛЛЕРГИЧЕСКИЙ РИНИТ ВОЗМОЖНОСТИ ЭФФЕКТИВНОЙ ТЕРАПИИALLERGIC RHINITIS: EFFICIENT THERAPEUTIC OPPORTUNITIESДербеневаМ. Л.DerbenevaM. L.

кандидат медицинских наук.

Москва. 

PhD in medicine.

Moscow.

 

ГусеваА. Л.GusevaA. L.

кандидат медицинских наук.

Москва. 

PhD in medicine.

Moscow.

 

Городская клиническая больница №1 им. Н.И. Пирогова Департамента здравоохранения г. Москвы.РоссияPirogov City Clinical Hospital No. 1 of the Moscow Healthcare Department.Russian FederationРоссийский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздрава России.РоссияPirogov Russian National Research Medical University of the Ministry of Health.Russian Federation2017060120180207679Copyright © Дербенева М.Л., Гусева А.Л., 20182018Дербенева М.Л., Гусева А.Л.Derbeneva M.L., Guseva A.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2233

В статье представлена эпидемиология, патогенез и классификация аллергического ринита. Обсуждаются возможности нефармакологических и фармакологических методов лечения этого заболевания, а также эффективность различных групп лекарственных препаратов для купирования симптомов аллергического ринита.

The article presents epidemiology, pathogenesis and classification of allergic rhinitis. The highlights of the article include nonpharmacological and pharmacological methods of treatment of this disease, and the efficacy of different groups of drugs for relief and management of allergic rhinitis symptoms.

аллергический риниттопические кортикостероидыфлутиказона пропионатallergic rhinitistopical corticosteroidsfluticasone propionateReferencesWallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CC, Schuller D, Spector SL, Tilles SA; Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol, 2008 Aug, 122(2 Suppl): S1-84. doi: 10.1016/j.jaci.2008.06.003.Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CC, Schuller D, Spector SL, Tilles SA; Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol, 2008 Aug, 122(2 Suppl): S1-84. doi: 10.1016/j.jaci.2008.06.003.Keith PK, Desrosiers M, Laister T, Schellenberg RR, Waserman S. The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients. Allergy Asthma Clin Immunol, 2012 Jun 1, 8(1): 7. doi: 10.1186/1710-1492-8-7.Keith PK, Desrosiers M, Laister T, Schellenberg RR, Waserman S. The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients. Allergy Asthma Clin Immunol, 2012 Jun 1, 8(1): 7. doi: 10.1186/1710-1492-8-7.Bousquet J,Van CauwenbergeP, Khaltaev N. Members of the Workshops. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic Rhinitis and its Impact on Asthma. Allergy, 2004 Apr, 59(4): 373-87. doi: 10.1111/j.1398-9995.2003.00468.x.Bousquet J,Van CauwenbergeP, Khaltaev N. Members of the Workshops. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic Rhinitis and its Impact on Asthma. Allergy, 2004 Apr, 59(4): 373-87. doi: 10.1111/j.1398-9995.2003.00468.x.Туровский А.В. Аллергический ринит: новое решение старой проблемы. Медицинский совет, 2016, 6: 44-50.Туровский А.В. Аллергический ринит: новое решение старой проблемы. Медицинский совет, 2016, 6: 44-50.Hay JW, Kaliner MA. Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective. Curr Med Res Opin, 2009 Jun, 25(6): 1421-31. doi: 10.1185/03007990902875992.Hay JW, Kaliner MA. Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective. Curr Med Res Opin, 2009 Jun, 25(6): 1421-31. doi: 10.1185/03007990902875992.Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev, 2011 Jul, 242(1): 31-50. doi: 10.1111/j.1600-065X.2011.01020.x.Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev, 2011 Jul, 242(1): 31-50. doi: 10.1111/j.1600-065X.2011.01020.x.Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol, 2010 Feb, 125(2 Suppl 2): S103-15. doi: 10.1016/j.jaci.2009.12.989.Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol, 2010 Feb, 125(2 Suppl 2): S103-15. doi: 10.1016/j.jaci.2009.12.989.Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol, 2001 Jul, 108(1 Suppl): S2-8.Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol, 2001 Jul, 108(1 Suppl): S2-8.Bruttmann G, Charpin D, Germouty J, Horak F, Kunkel G, Wittmann G. Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis. J Allergy Clin Immunol, 1989 Feb, 83(2 Pt 1): 411-6.Bruttmann G, Charpin D, Germouty J, Horak F, Kunkel G, Wittmann G. Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis. J Allergy Clin Immunol, 1989 Feb, 83(2 Pt 1): 411-6.Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L, Tozzi CA, Dass SB, Reiss TF. Efficacy of montelukast for treating perennial allergic rhinitis. Allergy Asthma Proc, 2007 MayJun, 28(3): 296-304.Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L, Tozzi CA, Dass SB, Reiss TF. Efficacy of montelukast for treating perennial allergic rhinitis. Allergy Asthma Proc, 2007 MayJun, 28(3): 296-304.Banov CH, Woehler TR, LaForce CF, Pearlman DS, Blumenthal MN, Morgan WF, Frazer H, Southern DL, Gold B, Field E. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy, 1994 Sep, 73(3): 240-6.Banov CH, Woehler TR, LaForce CF, Pearlman DS, Blumenthal MN, Morgan WF, Frazer H, Southern DL, Gold B, Field E. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy, 1994 Sep, 73(3): 240-6.Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surg, 2003 Dec, 129(6): 739-50.Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surg, 2003 Dec, 129(6): 739-50.Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S, Ryan D, Walker SM, Clark AT, Dixon TA, Jolles SR, Siddique N, Cullinan P, Howarth PH, Nasser SM, British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy, 2008 Jan, 38(1): 19-42.Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S, Ryan D, Walker SM, Clark AT, Dixon TA, Jolles SR, Siddique N, Cullinan P, Howarth PH, Nasser SM, British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy, 2008 Jan, 38(1): 19-42.Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung. Drug Res, 1998. 48: 956-960.Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung. Drug Res, 1998. 48: 956-960.Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf, 2000. 23 (1): 11–33.Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf, 2000. 23 (1): 11–33.Platt M. Pharmacotherapy for allergic rhinitis. Int Forum Allergy Rhinol, 2014 Sep, 4(Suppl 2): S35-40. doi: 10.1002/alr.21381.Platt M. Pharmacotherapy for allergic rhinitis. Int Forum Allergy Rhinol, 2014 Sep, 4(Suppl 2): S35-40. doi: 10.1002/alr.21381.Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, Bonini S, Boulet LP, Bousquet PJ, Brozek JL et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol, 2012 Nov, 130(5): 1049-62. doi: 10.1016/j.jaci.2012.07.053.Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, Bonini S, Boulet LP, Bousquet PJ, Brozek JL et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol, 2012 Nov, 130(5): 1049-62. doi: 10.1016/j.jaci.2012.07.053.

The authors declare that there are no conflicts of interest present.